QRxPharma : Appendix 4C - Quarter Ended 30 September 2015

Name of entity

QRxPharma Limited

ABN

Quarter ended ("current quarter")

16 102 254 151

30 September 2015

Cash flows related to operating activities

Current quarter

$A'000

Year to date (3 months)

$A'000

1.1

Receipts from customers

-

-

1.2

Payments for (a) staff costs

1. advertising and marketing

2. research and development

3. leased assets

4. other working capital

(68)

- (2)

- (436)

(68)

- (2)

- (436)

1.3

Dividends received

-

-

1.4

Interest and other items of a similar nature received

2

2

1.5

Interest and other costs of finance paid

-

-

1.6

Income taxes refund / (paid)

-

-

1.7

Other - Escrow account (deposit) / receipts(i) Other - Cost recoveries

Other - Research and development cash incentive received

49

-

-

49

-

-

Net operating cash flows

(455)

(455)

Current quarter

$A'000

Year to date (3 months)

$A'000

1.8

Net operating cash flows (carried forward)

(455)

(455)

Cash flows related to investing activities

-

-

-

-

-

-

-

-

-

-

1.9

Payment for acquisition of:

1. businesses (item 5)

2. equity investments

3. intellectual property

4. physical non-current assets

5. other non-current assets

1.10

Proceeds from disposal of:

1. businesses (item 5)

2. equity investments

3. intellectual property

4. physical non-current assets

5. other non-current assets

-

-

-

-

-

-

-

-

-

-

1.11

Loans to other entities

-

-

1.12

Loans repaid by other entities

-

-

1.13

Other (Bank Accepted Commercial bills and

Term Deposit with maturity greater than 3 months)

-

-

Net investing cash flows

-

-

1.14

Total operating and investing cash flows

(455)

(455)

Cash flows related to financing activities

-

-

1.15

Proceeds from issues of shares, options, etc.

1.16

Proceeds from sale of forfeited shares

-

-

1.17

Proceeds from borrowings

-

-

1.18

Repayment of borrowings

-

-

1.19

Dividends paid

-

-

1.20

Other

-

-

Net financing cash flows

-

-

Net increase (decrease) in cash held

(455)

(455)

1.21

Cash at beginning of quarter/year to date

3,073

3,073

1.22

Exchange rate adjustments to item 1.20

262

262

1.23

Cash at end of quarter

2,880

2,880

Current quarter

$A'000

1.24

Aggregate amount of payments to the parties included in item 1.2

-

1.25

Aggregate amount of loans to the parties included in item 1.11

-

2.1

Details of financing and investing transactions which have had a material effect on consolidated assets and liabilities but did not involve cash flows

Nil

2.2

Details of outlays made by other entities to establish or increase their share in businesses in which the reporting entity has an interest

Nil

Amount available

$A'000

Amount used

$A'000

3.1

Loan facilities

-

-

3.2

Credit standby arrangements

-

-

Reconciliation of cash at the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts is as follows.

Current quarter

$A'000

Previous quarter

$A'000

4.1

Cash on hand and at bank

2,880

3,073

4.2

Deposits at call

-

-

4.3

Bank overdraft

-

-

4.4

Bank Accepted Commercial Bills and Term Deposits with maturity of less than 3 months

-

-

Total: cash at end of quarter (item 1.23)

2,880

3,073

Acquisitions

(Item 1.9(a))

Disposals

(Item 1.10(a))

Nil

Nil